WPG Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78K Buy
80
+6
+8% +$308 ﹤0.01% 1041
2026
Q1
$4.39K Sell
74
-23
-24% -$1.49K ﹤0.01% 913
2025
Q4
$5.98K Sell
97
-16
-14% -$979 ﹤0.01% 857
2025
Q3
$7.05K Sell
113
-24
-18% -$1.67K 0.01% 802
2025
Q2
$10.9K Buy
137
+8
+6% +$669 0.01% 631
2025
Q1
$11.1K Buy
129
+31
+32% +$2.54K 0.01% 616
2024
Q4
$7.65K Buy
+98
New +$7.61K 0.01% 711

Other funds holding PBH

WPG Advisers's PBH Position: Q2 2026 in Review

WPG Advisers increased its Prestige Consumer Healthcare (PBH) stake by 8.1% in Q2 2026, buying an estimated $308 and bringing the position to 80 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

WPG Advisers first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.1K in Q1 2025. 134 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • WPG Advisers held 80 shares of Prestige Consumer Healthcare worth $3.78K as of Q2 2026.
  • WPG Advisers bought 6 Prestige Consumer Healthcare shares in Q2 2026, an estimated $308.
  • Prestige Consumer Healthcare made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1041 holding.
  • WPG Advisers first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Prestige Consumer Healthcare position peaked at $11.1K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.